Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MCAC Incontinence Panel Postponed; AMA Commends MCAC Executive Cmte.

This article was originally published in The Gray Sheet

Executive Summary

The Health Care Financing Administration will postpone the next scheduled meeting of a Medicare Coverage Advisory Committee panel following recent comments made by the MCAC Executive Committee.

You may also be interested in...

MCAC Panel Process Concerns Derail Ratification Of Initial Coverage Opinions

Standard procedures for conducting Medicare Coverage Advisory Committee panel reviews must be developed if future panel recommendations are to hold any chance of ratification, several members of MCAC's Executive Committee maintained at a Dec. 8 meeting.

HCFA Winnows Panel Agenda To Pelvic Floor Stimulation, Biofeedback

Medtronic's Interstim sacral nerve stimulation device for urinary incontinence treatment will not be reviewed as previously scheduled during the Health Care Financing Administration's Jan. 19-20 Medicare Coverage Advisory Committee meeting, agency staffers report.

Recent eMDR Change By FDA Asks Adverse Event Reporters About Third-Party Servicers

The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts